Form 8-K Loxo Oncology, Inc. For: Nov 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Loxo Oncology (LOXO) Posts Q3 Loss of 68c/Share
November 14, 2014 6:46 AM ESTLoxo Oncology (NASDAQ: LOXO) reported Q3 EPS of ($0.68), $0.31 worse than the analyst estimate of ($0.37).
Recent Business Highlights
Appointed Chief Medical Officer and New Director to the Board
The Company recently announced the... More
